Improved predictability of pancreatic ductal adenocarcinoma diagnosis using a blood immune cell biomarker panel developed from bulk mRNA sequencing and single-cell RNA-sequencing

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) remains a devastating cancer due to its poor survival rate, early detection, and resectability. This study aimed to determine the peripheral blood mononuclear cell (PBMC) immune biomarkers in patients with PDAC and investigate the PDAC-specific per...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Sung Ill, Lee, Hyung Keun, Chang, Eun-Ju, Kim, Somi, Kim, So Young, Hong, In Young, Kim, Jong Kyoung, Lee, Hye Sun, Yang, Juyeon, Cho, Jae Hee, Lee, Dong Ki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361912/
https://www.ncbi.nlm.nih.gov/pubmed/37165046
http://dx.doi.org/10.1007/s00262-023-03458-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361912/
https://www.ncbi.nlm.nih.gov/pubmed/37165046
http://dx.doi.org/10.1007/s00262-023-03458-8

Ejemplares similares